Vaginal Cancer

Risk Factors of Vaginal Cancer

There are various risk factors for vaginal cancer. Some are generic; for instance, lifestyle factors (diet, exercise, smoking, hygiene, stress), environment (poverty, exposure to chemicals). Mutations (changes in the gene) in specific genes involved in suppressing the tumours and regulating how cells divide and grow. Others are more specific to gynaecological cancers (viral infections, the formation of non-cancerous growths and bonding). Bonding refers to the number of sexual partners, early age at first interaction and type of bonding.

Viral Infections

Human Papillomavirus Infection

How does HPV affect the structure of the female reproductive system?

This is when high-risk HPV (16, 18) infects the lining of the reproductive system, predominantly the squamous cell lining. Abnormal growth of this lining is called dysplasia.
Dysplasia may arise in the cervix, vagina and vulva.
This process is called intraepithelial neoplasia. It can transition from hyperplasia (continuous growth) to low-grade dysplasia (non-cancerous) to high-grade dysplasia (non-cancerous) and then become cancerous if the viral HPV is not cleared.

The most common type of cancer arising from the lining is squamous cell carcinoma.
Abnormal cells in the cervix – cervical intraepithelial neoplasia
Abnormal cells in the vagina – vaginal intraepithelial neoplasia
Abnormal cells in the vulva – vulval intraepithelial neoplasia

The stages by which a non-cancerous lesion can develop into cancer.

How does HPV infect cells to become cancerous if not treated?

At first, the protein coat (capsid) of the virus binds to the cell and attaches. Then it enters the cell, targets the DNA, replicates (copies DNA), and divides to make little viruses (virions) and releases the new viruses to affect other cells in the lining uncontrollably.
This is recognised by the immune cells. However, some remain and continue to grow and become precancerous and, if not treated, cancer.
Researchers estimated that 5 to 10 years after HPV infection, cervical cells can become cancerous, and 20 years to become cancerous.

Immunosuppressants

These are drugs that suppress the immune system. They are commonly given when a patient is undergoing organ transplantation or autoimmune disease and rheumatic diseases. If a patient has a foreign organ donor enter the body, the immune system does not recognise it and combats it. Autoimmune diseases can be detected by abnormal levels of antibodies in the blood. There are different types of immunosuppresssants that target different immune cells to elicit their effects.

What Are Common Examples Of Autoimmune diseases?

A condition called systemic lupus erythematosus affects the body externally and internally. Skin is the major organ affected where there is a red butterfly rash on the face, cheek and bridge onof the nose. It can affect the kidneys, heart, lungs and brain by progressive attacks of inflammation and scarring of the tissue (fibrosis). A milder form is referred as discoid.

Verrucous Lupus

It is common to have warty lesions that form rare infections on the arm and hand.

Lupus Vulgaris.

It commonly begins during childhood, when there are dark red patches on the nose or cheek which can ulcerate and cause scarring. It can sometimes be associated with tuberculosis of the skin, where there is direct inoculation of the tuberculosis bacillus (bacterial infection) into the skin.
This is a histological image of the Verruca vulgaris. The epidermis has hyperkeratosis where there is increased growth based on the large size presented. There is also enlarged teeth-like dermal papillae which is referred as papillomatosis. However, the dermis layer which is directly below the epidermis, has thickened layer of epidermis that has descended down due to the hyperkeratosis (acanthosis). This is why there is a combination of epidermis and dermis in the dermal region.
The structure of the normal skin that is subdivided into epidermis, dermis and subcutaneous fatty tissue.

Younger women are more prone to HIV….

What Is HIV?

How Does HIV infection occurs?

The virus has an outer envelope and inner core. The inner core contains RNA and the enzyme “reverse transcriptase”. This helps the viral RNA to be transcribed from RNA to DNA. This is then added into the genome. The HIV surface glycoprotein gp120 binds to the CD4 molecule on host lymphocytes. Other cells that have the CD4 receptors are also affected. The CD4, HIV glycoprotein, chemokines (CCR5 and CXCR4) help the HIV to enter into cells and release the viral RNA. There is a progressive phase where there is depletion of the infected CD4 helper lymphocytes, which allows the host to be prone to infections with intracellular bacteria and mycobacteria.
HIV route to infection
This graph illustrates how when contact with a viral infection at Day 0. This is presented by the level of CD4+ lymphocytes at 1150 cells per millimetre. There are three phases: acute, chronic, and AIDs.
The HIV infection enters the acute phase if left untreated. The acute phase lasts between 6 and 12 weeks with flu-like symptoms, peak virus load, and low levels of CD4 T lymphocytes. There could also be mild glandular-like fever. The approximate peak level of HIV RNA copies per ml plasma is 10 to the power of 6 (viral load). The level of CD4 T lymphocytes is 500 cells per millimetre. There is an increase from week 6 to week 12, where the CD4 T lymphocytes increase from 500 to 650 cells per millimetre. The acute phase helps the virus to seed the lymphoid organs (thymus and spleen).
The level of HIV RNA copies per ml plasma steadily increases from 300 at week 9 to 500 HIV RNA copies per ml plasma at year 8. From 9 weeks to 7 years, there is a clinical latency period. The patient could be experiencing, with or without, persistent generalised abnormal lymph nodes (lymphadenopathy) which are > 1 cm in diameter at two or more extrainguinal sites (groin) for more than 3 months in the absence of causes other than HIV infection.
The chronic phase initiates after 12 weeks till 7 years. There is a descending trend from 650 CD4 + cells at week 12 till 11 years. There is a steady increase in HIV RNA copies until 7 years (setpoint viral load)
The AIDs phase then begins from year 7 to year 10. Here, there is an experience of constitutional symptoms and then opportunistic diseases in year 10, where the HIV RNA copies increase to 10 to the power of 5.  This reflects viral replication and declining CD4 + T lymphocytes to <200/mm3 (time to AIDS onset varies between individuals from as little as 2 years to more than 15 years after seroconversion). The opportunistic organisms are not considered pathogenic, and susceptibility increases as the patient becomes more immunocompromised.
The HIV RNA copies reaches its midpoint between 10 to the power of 6 and 10 to the power of 7 where death is experienced.
Source: Galvis, 2014

Previous gynaecological cancers and surgical treatment

Previous gynaecological cancers can be related to the vulva, cervix, womb (endometrium), colon and rectum in the past five years. This helps to distinguish metastasis and exclude original neoplasm being in the vagina.

Hysterectomy is the removal of the womb that commonly occurs for non-cancerous, benign, or malignant diseases. This is especially occurs in the upper third of the vagina in patients with post-hysterectomy, but minimal vagina lesions are found for those who have not been operated.

Exposure to in utero diethylstilbestrol (DES)

It is a female hormone that is synthetically made to prevent miscarriage.

This is commonly associated with adenocarcinoma, vaginal adenosis, and endometriosis, where there is a peak incidence before aged 30 years. It was first reported in the early 1970s, when vaginal disease is highest during the first trimester (three months). It can also appear in ovarian carcinoma and cancer of the fallopian tubes/oviduct.

It is common in younger women, as adenocarcinoma is not linked with DES exposure and mainly appears after menopause (cessation or stopping of the menstrual periods).

Vaginal Adenosis

Vaginal adenosis may appear in younger women who had exposure to in utero DES and may be linked to clear cell carcinoma. Vaginal adenosis is the growth of glandular epithelium in the area rather than squamous epithelium. Vaginal adenosis rarely progresses to adenocarcinoma.

However, the role of DES in vaginal cancer is now RARE because DES is no longer prescribed.

Moreover, vaginal adenosis may be associated with hormones, drugs, trauma, inflammation, and conditions like Stevens-Johnson syndrome, otherwise known as toxic epidermal necrolysis.

What Is Stevens-Johnson syndrome?

This is a condition following a reaction to a treatment. It begins with flu-like symptoms like high temperature, sore throat, cough, and joint pain. Later, there appears to be a rash made of circular patches that are darker in the middle and lighter on the outside. The rash then progresses to the upper body, affecting the face, arms, legs, and other parts, including the genitals. This can be itchy or painful. It is common in women who have a low immune system and exposure to cancer treatment like chemotherapy. Examples of medication include antibiotics that aim to kill or decrease the growth of bacteria, painkillers, and medicines prescribed for epilepsy. Epilepsy is a neurological condition characterised by seizures with a sudden onset.

For further information, please visit: https://www.nhs.uk/conditions/stevens-johnson-syndrome/

Other Health Conditions

Embryonal Rhabdomyosarcoma detected under the microscope
Yolk sac tumor present just below the vaginal stratified squamous epithelial lining (low power view – 10x). (Pant et al., 1970)
This is a schematic representation of how a normal (wild-type) and mutant DICER are processed. The double helix structure of the DNA unwinds and then serves as a template to transcribe the DNA sequences into RNA sequences. This forms a precursor (pre-miRNA), as presented in a diagram as a “hairpin”. The pre-miRNA then leaves the nucleus via the protein exportin 5. The role of DICER1 is then elucidated, where the pre-miRNA undergoes further processing with the help of the domains: RNase IIIa and RNase IIIb. This leads to cleaving the 3p and 5p miRNA, respectively. This degrades the hairpin structure (the 3” end of the passenger strand) but not the mature mRNA. Small single linear pieces of the miRNA are produced (the complementary piece is degraded within the cell). The single piece that has the miRNA is bound to the RNA-induced silencing complex (RISC), forming the RISC-miRNA complex. This complex then binds to the target mRNA strands.  This prevents the mRNA script from being translated by the ribosomes. There are two types of ribosomes: free ribosomes in the cytoplasm and those that are positioned on the outer structure of the Rough Endoplasmic Reticulum (RER). This does not allow the protein to be formed. In other words, the 3p and 5p miRNA are complexed with proteins to form an RNA silencing complex, which acts to target messenger RNA and destabilise translation or target it for degradation. On the other hand, mutant DICER1 processing prevents the cleavage of the pre-miRNA. RNase IIIb is blocked. This leads to the formation of the miRNA-miRNA loop. The miRNA-miRNA loop then leads to the degradation of the guide 5p’ strand. This prevents the RISC complex from being formed.  There is altered post-translational gene silencing. (Riascos et al. 2024)
There are two types of nucleic acids: Deoxyribonucleic acid (DNA) and Ribonucleic acid (RNA). Their function is to store, express, and transmit genetic information. The structure of the DNA helps it to store genetic information that codes for a sequence. It has two long polynucleotide strands that are coiled together to form a double helix. A polynucleotide refers to a chain of many nucleotides. poly = many. The structure of the nucleotide consists of a sugar, base, and phosphate group. The sugar has five sides, like a pentagon shape (pentose sugar); pent = 5. ose = sugar. The two strands are joined together because the base of each strand (purine) connects with the complementary base (pyrimidine) on the other strand by hydrogen bonds. This then leads to the formation of a ladder. The double helix then gets twisted to form a spiral shape. On the other hand, the RNA molecule is involved in decoding the information into instructions, i.e., a form of a template for linking a specific sequence of amino acids that codes for a protein (polypeptide chain). The structure of the RNA differs from the DNA as it has a single polynucleotide strand. Another difference is that there are different types of RNA. Some are involved in sending the mRNA template from the nucleus to the ribosomes (messenger RNA). Some are involved with helping to translate the code (tRNA). Some are involved in the formation of the ribosomes (rRNA). The ribosomes are structures found in the cell (the smallest unit of the cell) where the proteins are made. Other differences include the type of sugar and the types of bases found in RNA and DNA. DNA contains four main types of bases: thymine, cytosine, adenine, and guanine. Adenine pairs complementarily with thymine. Cytosine binds with guanine. On the other hand, RNA has three bases, with the exception of thymine. RNA has uracil, not thymine. Furthermore, the type of sugar found in ribonucleic acid (RNA) has no missing oxygen in its structure. On the other hand, deoxyribonucleic acid (DNA), as its name suggests, has the removal (de-) of an oxygen in its structure. The formation of proteins plays a critical role in all forms of life processes.

References

Adams, T.S., Maluleke, J.C. and Cuello, M.A. (2025). Cancer of the vagina: 2025 Update. International Journal of Gynecology & Obstetrics, 171(S1), pp.48–59. doi:10.1002/ijgo.70325.

Archila, L.R., Balakrishnan, R., Boroujeni, A.M., Chiang, S., Ellenson, L., Connelly, C., Bowman, A., Vanderbilt, C., Agaram, N., Abu-Rustum, N., Hensley, M. and Park, K. (2026). 1048 HPV-Associated sarcomas of the cervix and vagina – detection of common (16, 51) and rare (30, 90, 114) HPV types, recurrent ATRX alterations and wild-type TP53/RB1 By next-generation sequencing (NGS). Laboratory Investigation, 106(3), p.105338. doi:10.1016/j.labinv.2025.105338.

Cancer Research UK (2027) Vaginal intraepithelial neoplasia (VAIN) Available at: https://www.cancerresearchuk.org/about-cancer/vaginal-cancer/vain (Accessed: 11th October 2026)

Cassidy, J., Bissett, D., Spene, R. and Payne, M. (2010) Oxford Handbook of Oncology. Oxford: Oxford University Press.

MedlinePlus (2016) DICER1 syndrome. Available at: https://medlineplus.gov/genetics/condition/dicer1-syndrome/#inheritance (Accessed: 8th October 2026)

National Cancer Institute (2025) HPV and Cancer. Available at: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer (Accessed: 6th August 2026)

National Institute of Care and excellence Gynaecological cancers – recognition and referral: Presentation. Available at: https://cks.nice.org.uk/topics/gynaecological-cancers-recognition-referral/background-information/presentation/ Accessedl 7th August 2026.

Nout, R.A., Calaminus, G., Planchamp, F., Chargari, C., Lax, S., Martelli, H., McCluggage, W.G., Morice, P., Pakiz, M., Schmid, M.P., Stunt, J., Timmermann, B., Vokuhl, C., Orbach, D. and Fotopoulou, C. (2023). ESTRO/ESGO/SIOPe Guidelines for the management of patients with vaginal cancer. International Journal of Gynecologic Cancer, [online] 33(8). doi:10.1136/ijgc-2023-004695.

Pant, A.D., Sayami, G., Prasad, V. and Shrestha, A. (1970). A rare case of yolk sac tumor of the vagina: Cytology and histopathological findings. Nepal Journal of Obstetrics and Gynaecology, 1(2), pp.63–65. doi:10.3126/njog.v1i2.2402.

Riascos, M.C., Huynh, A., Faquin, W.C. and Nosé, V. (2024). Expanding our knowledge of DICER1 gene alterations and their role in thyroid diseases. Cancers, [online] 16(2), p.347. doi:10.3390/cancers16020347.

Torres Galvis, A.E. (2014). An RNA lariat intermediate in HIV-1 cdna synthesis. Available at: https://www.researchgate.net/publication/284360827_An_RNA_Lariat_Intermediate_in_HIV-1_cDNA_Synthesis (Accessed: 23rd Octoer 2026)

Pages: 1 2 3 4 5 6 7

13 responses to “Vaginal Cancer”

  1. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal Cancers Cancer of the Vagina 2025 updateDownload ESTRO,ESGO,SIOPe guidelines […]

    Like

  2. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

  3. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

  4. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

  5. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

  6. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

  7. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

  8. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

  9. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

  10. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

  11. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

  12. […] Me Cancer Project Cancer Awareness Month September Cancer Awareness Month Gynaecological Cancers Vaginal Cancers Treatment of Vaginal […]

    Like

Leave a Reply